R. Le-gène, la sous unité ? du Core Binding Factor (CBF), est un facteur transcriptionnel hétérodimérique. Il joue un rôle clef dans la régulation de l'hématopoïèse

H. Miyoshi, Cette translocation est plus fréquente dans les LAM 2 de la classification FAB et représente 18 à 20 % des anomalies chromosomiques dans toutes les LAM C'est l'une des cibles la plus fréquente des translocations chromosomiques, Licht JDHuret JL Atlas Genet Cytogenet Oncol Haematol, 1991.

. Récemment, une fonction « gate keeper » (garde-barrière ou cerbère) a été suggérée pour RUNX1 dans les leucémies aigues, Cette désignation fait suite aux observations de mutations qui paraissent suffisantes pour provoquer une leucémie aigue dans des translocations impliquant ce gène, 2008.

V. Coiteux, R. Onclercq-delic, and P. Fenaux, Predisposition to therapy-related leukemia with balanced chromosomal translocations does not result from a major constitutive defect in DNA douuble-strand break end joining, Leuk Research, pp.31-353, 2007.

D. Croucher, D. Saunders, S. Lobov, and M. Ranson, Revisiting the biological roles of PAI2 (SERPINB2) in cancer, Nature Reviews Cancer, vol.276, issue.7, pp.535-545, 2008.
DOI : 10.1038/nrc2400

R. Curtis, J. Boice, . Jr, and M. Stovall, Risk of Leukemia after Chemotherapy and Radiation Treatment for Breast Cancer, New England Journal of Medicine, vol.326, issue.26, pp.326-1745, 1992.
DOI : 10.1056/NEJM199206253262605

D. 'alò, F. Fianchi, L. Fabiani, and E. , Similarties and differencies between therapy-related and elderly acute myeloid leukemia, Mediterr J Hematol Infect Dis, vol.3, issue.1, p.2011052, 2011.

W. Dameshek, Editorial-The Treatment of Polycythemia, Blood, issue.1, p.256, 1946.

D. Amours, D. Jackson, and S. , The mre11 complex: at the crossroads of dna repair and checkpoint signalling, Nature Reviews Molecular Cell Biology, vol.3, issue.5, pp.317-327, 2002.
DOI : 10.1038/nrm805

S. Davies, L. Robison, and J. Buckley, -Transferase Polymorphisms and Outcome of Chemotherapy in Childhood Acute Myeloid Leukemia, Journal of Clinical Oncology, vol.19, issue.5, pp.1279-87, 2001.
DOI : 10.1200/JCO.2001.19.5.1279
URL : https://hal.archives-ouvertes.fr/hal-00309864

I. Day, . Rs, . Ziolkowski, and D. Scudiero, Defective repair of alkylated DNA by human tumour and SV-40-transformed human cell strains, Nature, issue.5792, pp.288-724, 1980.

C. Deambrogi, D. Paoli, L. Fangazio, and M. , Analysis of the REL, BCL11A, and MYCN proto-oncogenes belonging to the 2p amplicon in chronic lymphocytic leukemia, American Journal of Hematology, vol.111, issue.7, pp.85-541, 2010.
DOI : 10.1002/ajh.21742
URL : https://hal.archives-ouvertes.fr/hal-00552328

L. Detourmignies, S. Castaigne, and A. Stoppa, Therapy-related acute promyelocytic leukemia: a report on 16 cases., Journal of Clinical Oncology, vol.10, issue.9, pp.1430-1435, 1992.
DOI : 10.1200/JCO.1992.10.9.1430

Y. Ding, Y. Harada, and J. Imagawa, AML1/RUNX1 point mutation possibly promotes leukemic transformation in myeloproliferative neoplasms, Blood, vol.114, issue.25, pp.114-5201, 2009.
DOI : 10.1182/blood-2009-06-223982

A. Dixon-mciver, P. East, and C. Mein, Distinctive Patterns of MicroRNA Expression Associated with Karyotype in Acute Myeloid Leukaemia, PLoS ONE, vol.5, issue.5, p.2141, 2008.
DOI : 10.1371/journal.pone.0002141.s006

K. Döhner, K. Tobis, and R. Ulrich, Gene in Adult Patients 16 to 60 Years Old With Acute Myeloid Leukemia and Normal Cytogenetics: A Study of the Acute Myeloid Leukemia Study Group Ulm, Journal of Clinical Oncology, vol.20, issue.15, pp.20-3254, 2002.
DOI : 10.1200/JCO.2002.09.088

K. Döhner, R. Schlenk, and M. Habdanck, Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations, Blood, vol.106, issue.12, pp.106-3740, 2005.
DOI : 10.1182/blood-2005-05-2164

F. Forghieri, M. Morcelli, and L. Potenza, Chronic eosinophilic leukaemia with ETV6-NTRK3 fusion transcript in an elderly patient affected with pancreatic carcinoma, European Journal of Haematology, vol.21, issue.4, pp.352-355, 2011.
DOI : 10.1111/j.1600-0609.2011.01576.x

P. Fortini, B. Pascucci, and E. Parlanti, The base excision repair: mechanisms and its relevance for cancer susceptibility, Biochimie, vol.85, issue.11, pp.851053-1071, 2003.
DOI : 10.1016/j.biochi.2003.11.003

E. Friedberg, How nucleotide excision repair protects against cancer, Nature Reviews Cancer, vol.1, issue.1, pp.22-33, 2001.
DOI : 10.1038/35094000

E. Friedberg, DNA damage and repair, Nature, vol.75, issue.6921, pp.421436-440, 2003.
DOI : 10.1038/nature01408

E. Friedberg, A. Lehmann, and R. Fuchs, Trading Places: How Do DNA Polymerases Switch during Translesion DNA Synthesis?, Molecular Cell, vol.18, issue.5, pp.499-505, 2005.
DOI : 10.1016/j.molcel.2005.03.032
URL : http://doi.org/10.1016/j.molcel.2005.03.032

S. Fröhling, R. Schlenk, and J. Breitruk, Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm, Blood, vol.100, issue.13, pp.100-4372, 2002.
DOI : 10.1182/blood-2002-05-1440

S. Fröhling, R. Schlenk, and I. Stolze, Mutations in Younger Adults With Acute Myeloid Leukemia and Normal Cytogenetics: Prognostic Relevance and Analysis of Cooperating Mutations, Journal of Clinical Oncology, vol.22, issue.4, pp.624-633, 2004.
DOI : 10.1200/JCO.2004.06.060

R. Fuchs and A. Tissier, Réparation de l'ADN et cancer. Cancérologie fondamentale, John Libbey Eurotext, vol.1, 2005.

J. Gaillard, J. Chiesa, and D. Reboul, Monosomal karyotype routinely defins a poor prognosis subgroup in acute myeloid leukemia is frequently associated with TP53 deletion

R. Garzon, M. Fabbri, A. Cimmino, G. Calin, and C. Croce, MicroRNA expression and function in cancer, Trends in Molecular Medicine, vol.12, issue.12, pp.12-580, 2006.
DOI : 10.1016/j.molmed.2006.10.006

J. Ginsberg, E. De-alava, and M. Ladanyi, Gene Fusions Are Associated With Similar Clinical Phenotypes in Ewing's Sarcoma, Journal of Clinical Oncology, vol.17, issue.6, pp.17-1809, 1999.
DOI : 10.1200/JCO.1999.17.6.1809

L. Godley and R. Larson, Therapy-Related Myeloid Leukemia, Seminars in Oncology, vol.35, issue.4, pp.418-429, 2008.
DOI : 10.1053/j.seminoncol.2008.04.012

T. Golub, D. Slonim, and P. Tamayo, Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring, Science, vol.286, issue.5439, pp.286-531, 1999.
DOI : 10.1126/science.286.5439.531

T. Golub, G. Barker, and M. Lovett, Fusion of PDGF receptor ?? to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation, Cell, vol.77, issue.2, pp.77-307, 1994.
DOI : 10.1016/0092-8674(94)90322-0

R. Goth-goldstein, Inability of chinease hamster ovary cells to excise O6-alkylguanine Cancer Research, pp.40-2623, 1980.

R. Goth and M. Rajewsky, Persistence of O6 ethylguanine in rat brain DNA:correlation with nervous system and carcinogenesis by nitrosourea Proceeding of the National Academy of Sciences of the USA, pp.71-639, 1974.

P. Gout, A. Buckley, C. Simms, and N. Bruchovsky, Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the xc??? cystine transporter: a new action for an old drug, Leukemia, vol.15, issue.10, pp.151633-1640, 2001.
DOI : 10.1038/sj.leu.2402238

T. Gorletta, P. Gasparini, D. Elios, and M. , Frequent loss of heterozygosity without loss of genetic material in acute myeloid leukemia with a normal karyotype, Genes, Chromosomes and Cancer, vol.102, issue.3, pp.334-337, 2005.
DOI : 10.1002/gcc.20234

M. Gordon, L. Kearney, and J. Hibbin, Effects of human bone marrow stromal cells proliferation by human granulocytic (GM-CFC), erythroid (BFU-E) and mixed (Mix-CFC) colony-forming cells, Br J Heamatol, issue.2, pp.53-317, 1983.

M. Gross, H. Mkrtchyan, and M. Glaser, Delineation of yet unkwown cryptic subtelomere aberration in 50% of acute myeloid leukemia with GTG-banding karyotype, Int J Oncol, vol.34, issue.2, pp.417-423, 2009.

V. Guillem and M. Tormo, Influence of DNA damage and repair upon the risk of treatment related leukemia, Leukemia & Lymphoma, vol.3, issue.2, pp.204-217, 2008.
DOI : 10.1038/sj.bmt.1705547

J. Gwak, S. Jung, and D. Kang, Stimulation of protein kinase C-alpha suppresses colon cancer cell proliferation by down-regulation of beta-catenin, J Cell Mol Med, issue.8B, pp.13-2171, 2009.

C. Haferlach, F. Dicker, and H. Herholz, Mutations of the TP53 gene in acute myeloid leukemia are strongly associated with a complex aberrant karyotype, Leukemia, vol.96, issue.8, pp.22-1539, 2008.
DOI : 10.1038/leu.2008.143

Y. Han, J. Chen, and X. Zhao, MicroRNA Expression Signatures of Bladder Cancer Revealed by Deep Sequencing, PLoS ONE, vol.44, issue.15, pp.6-18286, 2011.
DOI : 10.1371/journal.pone.0018286.s005

H. Harada, Y. Harada, and H. Tanaka, Implications of somatic mutations in the AML1 gene in radiation-associated and therapy-related myelodysplastic syndrome/acute myeloid leukemia, Blood, vol.101, issue.2, pp.673-680, 2003.
DOI : 10.1182/blood-2002-04-1010

Y. Harada and H. Harada, Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations, Journal of Cellular Physiology, vol.49, issue.1, pp.16-20, 2009.
DOI : 10.1002/jcp.21769

Y. Harada and H. Harada, point mutations, Journal of Cellular Biochemistry, vol.49, issue.2, pp.425-438, 2011.
DOI : 10.1002/jcb.22974

A. Hart, C. Corrick, and M. Tymms, Human ERG is a proto-oncogene with mitogenic and transforming activity, Oncogene, issue.7, pp.10-1423, 1995.

V. Havelange, R. Garzon, and C. Croce, MicroRNAs: new players in acute myeloid leukaemia, British Journal of Cancer, vol.17, issue.5
DOI : 10.1016/j.tig.2004.09.010

I. Hayata, T. Ishihara, and K. Hirashima, Partial deletion of chromosome No. 2 in myelocytic leukemias of irradiated C3H/He and RFM mice, J Natl Cancer Inst, issue.3, pp.63-843, 1979.

J. Hayes and D. Pulford, The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance, Crit Rev Biochem Mol Biol, issue.6, pp.30-445, 1995.

S. Heinrichs, C. Li, and A. Look, SNP array analysis in hematologic malignancies: avoiding false discoveries, Blood, vol.115, issue.21, pp.115-4157, 2010.
DOI : 10.1182/blood-2009-11-203182

P. Ho, T. Alonzo, and K. Kopecky, Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study, Leukemia, vol.102, issue.5, pp.24-909, 2010.
DOI : 10.1111/j.1582-4934.2009.00876.x

J. Hoeijmakers, Genome maintenance mechanisms for preventing cancer, Nature, issue.6835, pp.411366-374, 2001.

X. Hu, M. Stern, and L. Ge, Genetic Alterations and Oncogenic Pathways Associated with Breast Cancer Subtypes, Molecular Cancer Research, vol.7, issue.4, pp.511-522, 2009.
DOI : 10.1158/1541-7786.MCR-08-0107

L. Johnson, K. Mercer, and D. Greenbaum, Somatic activation of the K-ras oncogene causes early onset lung cancer in mice, Nature, issue.6832, pp.410-1111, 2001.

J. Joslin, A. Fernald, and T. Tr, Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders, Blood, vol.110, issue.2, pp.719-726, 2007.
DOI : 10.1182/blood-2007-01-068809

J. Joung, Y. Lee, and S. Park, Haplotype Analysis of Prostate Stem Cell Antigen and Association With Prostate Cancer Risk, The Journal of Urology, vol.185, issue.6, pp.185-2112, 2011.
DOI : 10.1016/j.juro.2011.01.083

B. Kaina, A. Van-zeeland, and A. De-groot, DNA repair and chromosomal stability in the alkylating agent-hypersensitive Chinese hamster cell-line 27-1 Mutation Research, pp.219-224

A. Kallioniemi, O. Kallioniemi, and D. Sudar, Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors, Science, vol.258, issue.5083, pp.258-818, 1992.
DOI : 10.1126/science.1359641

R. Kalra, D. Paderanga, and K. Olson, Genetic analysis is consistent with the hypothesis that NFl limits myeloid cell growth through p21 ras, Blood, issue.10, pp.84-3435, 1994.

X. Karp and A. V. , DEVELOPMENTAL BIOLOGY: Enhanced: Encountering MicroRNAs in Cell Fate Signaling, Science, vol.310, issue.5752, pp.310-1288, 2005.
DOI : 10.1126/science.1121566

P. Karran, Mechanisms of tolerance to DNA damaging therapeutic drugs Carcinogenesis, pp.22-1931, 2001.

E. Katzaki, G. Morin, and M. Pollazzon, Syndromic mental retardation with thrombocytopenia due to 21q22.11q22.12 deletion: Report of three patients, American Journal of Medical Genetics Part A, vol.8, issue.7, pp.152-1711
DOI : 10.1002/ajmg.a.33478

H. Kawagoe, R. Humphries, and A. Blair, Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells, Leukemia, vol.13, issue.5, pp.13-687, 1999.
DOI : 10.1038/sj.leu.2401410

S. Kayser, K. Döhner, and J. Krauter, The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML, Blood, vol.117, issue.7, pp.117-2137, 2011.
DOI : 10.1182/blood-2010-08-301713

S. Kayser, M. Zucknick, and K. Döhner, Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies, Blood, vol.119, issue.2, pp.551-558, 2012.
DOI : 10.1182/blood-2011-07-367508

M. Kim, J. Stewart, and C. Delvin, The application of comparative genomic hybridization as an additional tool in the chromosome analysis of acute myeloid leukemia and myelodysplastic syndromes, Cancer Genetics and Cytogenetics, vol.126, issue.1, pp.26-33, 2001.
DOI : 10.1016/S0165-4608(00)00386-1

A. Kittang, K. Hatfield, and K. Sand, The Chemokine Network in Acute Myelogenous Leukemia: Molecular Mechanisms Involved in Leukemogenesis and Therapeutic Implications
DOI : 10.1007/82_2010_25

N. Kondo, A. Takahashi, and K. Ono, DNA damage induced by alkylating agents and repair pathways J of Nucleic Acids, p.543531, 2010.

O. Kosmider, E. Delabesse, and V. Mas, TET2 mutations in secondary acute myeloid leukemias: a French retrospective study, Haematologica, vol.96, issue.7, pp.96-1059, 2011.
DOI : 10.3324/haematol.2011.040840

P. Kottaridis, R. Gale, and M. Frew, The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials, Blood, vol.98, issue.6, pp.98-1752, 2001.
DOI : 10.1182/blood.V98.6.1752

J. Kralik, W. Kranewitter, and H. Boesmueller, Characterization of a newly identified ETV6-NTRK3 fusion transcript in acute myeloid leukemia, Diagnostic Pathology, vol.6, issue.1, 2011.
DOI : 10.1128/MCB.24.11.4636-4650.2004

E. Kruse, S. Loughran, and T. Baldwin, Dual requirement for the ETS transcription factors Fli-1 and Erg in hematopoietic stem cells and the megakaryocyte lineage, Proceedings of the National Academy of Sciences, vol.106, issue.33, pp.106-13814, 2010.
DOI : 10.1073/pnas.0906556106

E. Kurz and S. Lees-miller, DNA damage-induced activation of ATM and ATM-dependent signaling pathways, DNA Repair, vol.3, issue.8-9, pp.8-9889, 2004.
DOI : 10.1016/j.dnarep.2004.03.029

M. Kühn, I. Radtke, and L. Bullinger, High-resolution genomic profiling of adult and pediatric core-binding factor acute myeloid leukemia reveals new recurrent genomic alterations, Blood, vol.119, issue.10, pp.119-67, 2012.
DOI : 10.1182/blood-2011-09-380444

F. Lai, L. Godley, and J. Joslin, Transcript Map and Comparative Analysis of the 1.5-Mb Commonly Deleted Segment of Human 5q31 in Malignant Myeloid Diseases with a del(5q), Genomics, vol.71, issue.2
DOI : 10.1006/geno.2000.6414

R. Lange, W. Moloney, and T. Yamawaki, Leukemia in Atomic Bomb Survivors: I. General Observations, Blood, issue.96, pp.574-585, 1954.

T. Langer, M. Metzler, and D. Reinhardt, Analysis of t(9;11) chromosomal breakpoint sequences in childhood acute leukemia: Almost identicalMLL breakpoints in therapy-related AML after treatment without etoposides, Genes, Chromosomes and Cancer, vol.83, issue.4, pp.393-401, 2003.
DOI : 10.1002/gcc.10167

C. Lannon and P. Sorensen, ETV6???NTRK3: a chimeric protein tyrosine kinase with transformation activity in multiple cell lineages, Seminars in Cancer Biology, vol.15, issue.3, pp.15-215, 2005.
DOI : 10.1016/j.semcancer.2005.01.003

G. Lakhanpal, L. Vecchiarelli-federico, and Y. Li, The inositol phosphatase SHIP-1 is negatively regulated by Fli-1 and its loss accelerates leukemogenesis, Blood, vol.116, issue.3, pp.428-436, 2010.
DOI : 10.1182/blood-2009-10-250217

A. Larsen, A. Escargueil, and A. Skladanowski, From DNA damage to G2 arrest: the many roles of topoisomerase II, Prog Cell Cycle Res, vol.5, pp.295-300, 2003.
URL : https://hal.archives-ouvertes.fr/hal-00257591

R. Larson, L. Beau, M. Ratain, M. Rowley, and J. , Balanced translocations involving chromosome bands 11q23 and 21q22 in therapy-related leukemia, Blood, issue.7, pp.79-1892, 1992.

R. Larson, Y. Wang, and M. Banerjee, Prevalence of the inactivating 609C-->T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapyrelated myeloid leukemia, Blood, issue.2, pp.94-803, 1999.

R. Larson, L. Beau, and M. , Therapy-related myeloid leukemia. A model for leukemogenesis in humans, Chemico-Biological Interactions, pp.153-154, 2005.

L. Beau, M. Albain, K. Larson, and R. Vardiman, Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7, J Clin Oncol, issue.3, pp.4-325, 1986.

J. Lejeune, R. Berger, and M. Haines, Constitution d'un clone à 54 chromosome au cours d'une leucoblastose congénitale chez une enfant mongolienne, CRAS, vol.256, pp.1195-1197, 1963.

V. Lemarchandel, J. Ghysdael, and V. Mognotte, GATA and Ets cis-acting sequences mediate megakaryocyte-specific expression., Molecular and Cellular Biology, vol.13, issue.1, pp.668-676, 1993.
DOI : 10.1128/MCB.13.1.668
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC358945

G. Leone, L. Pagano, D. Ben-yehuda, and M. Voso, Therapy-related leukemia and myelodysplasia: susceptibility and incidence, Haematologica, vol.92, issue.10, pp.92-1389, 2007.
DOI : 10.3324/haematol.11034
URL : http://doi.org/10.3324/haematol.11034

D. Leprince, A. Gegonne, and J. Coll, A putative second cell-derived oncogene of the avian leukaemia retrovirus E26, Nature, vol.304, issue.5941, pp.306395-397, 1983.
DOI : 10.1016/0092-8674(83)90513-5

L. Toriellec, E. Despouy, G. , and P. , Haploinsufficiency of CDKN1B contributes to leukemogenesis in T-cell prolymphocytic leukemia, Blood, vol.111, issue.4, pp.2321-2328, 2008.
DOI : 10.1182/blood-2007-06-095570

E. Lewis, Leukemia and ionizing radiation, Science, issue.3255, pp.125-965, 1957.

T. Ley, E. Mardis, and L. Ding, DNA sequencing of a cytogeneticlly normal acute myeloid leukaemia genome, Nature, issue.7218, pp.456-66, 2008.

A. Li, J. King, and A. Moro, Overexpression of CXCL5 Is Associated With Poor Survival in Patients With Pancreatic Cancer, The American Journal of Pathology, vol.178, issue.3, pp.1340-1349, 2011.
DOI : 10.1016/j.ajpath.2010.11.058

J. Licht, AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML, Oncogene, vol.20, issue.40, pp.20-5660, 2001.
DOI : 10.1038/sj.onc.1204593

M. Lieber, The Mechanism of Double-Strand DNA Break Repair by the Nonhomologous DNA End-Joining Pathway, Annual Review of Biochemistry, vol.79, issue.1, pp.181-211, 2010.
DOI : 10.1146/annurev.biochem.052308.093131

D. Linck, L. Schuettpelz, and D. Shen, Identification of a novel TP53 cancer susceptibility mutation through whole-genome sequencing of a patient with therapy-related AML, JAMA, issue.15, pp.305-1568, 2011.

D. Lieberman, D. Meytes, and N. Schacked, Hulan bone marrow fibroblast proliferation and GM-CFC colony formation in patients with acute leukemia, Acta Haematol, issue.5, pp.72-309, 1984.

M. Litchman, Is there an entity of chemically induced BCR-ABL positve chronic myelogenous leukemia? The Oncologist, pp.645-654, 2008.

J. Little, Genomic instability and bystander effects: a historical perspective, Oncogene, vol.22, issue.45, pp.22-6978, 2003.
DOI : 10.1038/sj.onc.1206988

L. Liu, Y. Nakatsuru, and S. Gerson, Base Excision Repair as a Therapeutic Target in Colon Cancer, Clin Cancer Res, vol.8, issue.9, pp.2985-2991, 2002.

W. Liu, H. Lee, and Y. Liu, Olfactomedin 4 is a novel target gene of retinoic acids and 5-aza-2'-deoxycytidine involved in human myeloid leukemia cell growth, differentiation, and apoptosis, Blood, vol.116, issue.23, pp.116-4938, 2010.
DOI : 10.1182/blood-2009-10-246439

X. Liu, X. Li, and B. Zhaug, MicroRNA-26b is underexpressed in human breast cancer and induces cell apoptosis by targeting SLC7A11, FEBS Letters, vol.32, issue.9, pp.585-1363, 2011.
DOI : 10.1016/j.febslet.2011.04.018

Y. Liu, S. Elf, and Y. Miyata, p53 Regulates Hematopoietic Stem Cell Quiescence, Cell Stem Cell, vol.4, issue.1, pp.37-48, 2009.
DOI : 10.1016/j.stem.2008.11.006
URL : http://doi.org/10.1016/j.stem.2008.11.006

S. Loughran, E. Kruse, and D. Hacking, The transcription factor Erg is essential for definitive hematopoiesis and the function of adult hematopoietic stem cells, Nature Immunology, vol.36, issue.7, pp.810-819, 2008.
DOI : 10.1038/ni.1617

B. Lovett, D. Strumberg, and I. Blair, Etoposide Metabolites Enhance DNA Topoisomerase II Cleavage near Leukemia-Associated MLL Translocation Breakpoints, Biochemistry, issue.5, pp.40-1159, 2001.
DOI : 10.1021/bi002361x
URL : http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.196.3518

D. Ludlum, DNA alkylation by the haloethylnitrosoureas: Nature of modifications produced and their enzymatic repair or removal, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol.233, issue.1-2, pp.117-126, 1990.
DOI : 10.1016/0027-5107(90)90156-X

W. Lui, L. Zeng, and V. Rehrmann, CREB3L2-PPARgamma fusion mutation identifies a thyroid signaling pathway regulated by intramembrane proteolysis, Cancer Res, issue.17, pp.68-7156, 2008.

Y. Ma, H. Lu, and B. Tippin, A Biochemically Defined System for Mammalian Nonhomologous DNA End Joining, Molecular Cell, vol.16, issue.5, pp.16-701, 2004.
DOI : 10.1016/j.molcel.2004.11.017

R. Mackinnon, G. Kannourakis, M. Wall, and L. Campbell, A cryptic deletion in 5q31.2 provides further evidence for a minimally deleted region in myelodysplastic syndromes, Cancer Genetics, vol.204, issue.4, pp.187-194, 2011.
DOI : 10.1016/j.cancergen.2011.02.001

R. Mackinnon, C. Selan, and A. Zordan, CGH and SNP array using DNA extracted from fixed cytogenetic preparations and long-term refrigerated bone marrow specimens, Molecular Cytogenetics, vol.5, issue.1
DOI : 10.1002/gcc.20385

J. Malfuson and J. Konopacki, Therapy-related myeloproliferative neoplasm with ETV6-PDGFRB rearrangement following treatment of acute promyelocytic leukemia, Annals of Hematology, vol.95, issue.9, 2011.
DOI : 10.1007/s00277-011-1188-1

Z. Mamuris, M. Prieur, and B. Dutrillaux, The chemotherapeutic drug melphalan induces breakage of chromosomes regions rearranged in secondary leukemia, Cancer Genetics and Cytogenetics, vol.37, issue.1, pp.65-77, 1989.
DOI : 10.1016/0165-4608(89)90076-9

G. Marcucci, K. Maharry, and Y. Wu, Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study, Journal of Clinical Oncology, vol.28, issue.14, pp.28-2348, 2010.
DOI : 10.1200/JCO.2009.27.3730

E. Mardis, L. Ding, and D. Dooling, Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome, New England Journal of Medicine, vol.361, issue.11, pp.361-1058, 2009.
DOI : 10.1056/NEJMoa0903840

A. Martinez-ramerez, M. Urioste, and M. Calasanz, Array comparative genomic hybridization analysis of myelodysplastic syndromes with complex karyotypes. A technical evaluation, Cancer Genetics and Cytogenetics, vol.144, issue.1, pp.87-89, 2003.
DOI : 10.1016/S0165-4608(02)00930-5

A. Mays, N. Osheroff, and Y. Xiao, Evidence for direct involvement of epirubicin in the formation of chromosomal translocations in t(15;17) therapy-related acute promyelocytic leukemia, Blood, vol.115, issue.2, pp.115-326, 2010.
DOI : 10.1182/blood-2009-07-235051

K. Meletis, V. Wirta, and S. Hede, p53 suppresses the self-renewal of adult neural stem cells, Development, vol.133, issue.2, pp.363-369, 2006.
DOI : 10.1242/dev.02208

D. Meek, Tumour suppression by p53: a role for the DNA damage response?, Nature Reviews Cancer, vol.20, issue.910, pp.714-723, 2009.
DOI : 10.1038/nrc2716

M. Midmer, R. Haq, and J. Squire, Identification of NKIAMRE, the human homologue to the mitogen-activated protein kinase-/cyclin-dependent kinase-related protein kinase NKIATRE, and its loss in leukemic blasts with chromosome arm 5q deletion, Cancer Res, issue.16, pp.59-4069, 1999.

M. Missen, D. Haylock, and G. Whitty, Stage specific gene expression of serpins and their cognate proteases during myeloid differentiation, British Journal of Haematology, vol.263, issue.5, pp.715-724, 1999.
DOI : 10.1126/science.8290962

A. Mistry, C. Felix, and R. Whitmarsh, DNA Topoisomerase II in Therapy-Related Acute Promyelocytic Leukemia, New England Journal of Medicine, vol.352, issue.15, pp.352-1529, 2005.
DOI : 10.1056/NEJMoa042715

F. Mitelman, Y. Kaneko, and J. Trent, Report of the committee on chromosome changes in neoplasia, Cytogenet Cell Genet, vol.55, pp.1-4, 1990.

H. Miyoshi, K. Shimizu, and T. Kozu, t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1., Proceedings of the National Academy of Sciences, vol.88, issue.23, pp.88-10431, 1991.
DOI : 10.1073/pnas.88.23.10431

J. Monnier and M. Samson, Prokineticins in angiogenesis and cancer, Cancer Letters, vol.296, issue.2, pp.144-149, 2010.
DOI : 10.1016/j.canlet.2010.06.011
URL : https://hal.archives-ouvertes.fr/hal-00684728

Y. Mori, A. Olam, and Y. Cehg, Novel candidate colorectal cancer biomarkers identified by methylation microarray-based scanning, Endocrine Related Cancer, vol.18, issue.4, pp.465-478, 2011.
DOI : 10.1530/ERC-11-0083

K. Mrózek, N. Heerema, and C. Bloomfield, Cytogenetics in acute leukemia, Blood Reviews, vol.18, issue.2, pp.115-136, 2004.
DOI : 10.1016/S0268-960X(03)00040-7

K. Mrozek, Cytogenetic, Molecular Genetic, and Clinical Characteristics of Acute Myeloid Leukemia With a Complex Karyotype, Seminars in Oncology, vol.35, issue.4, pp.365-377, 2008.
DOI : 10.1053/j.seminoncol.2008.04.007

A. Mullally and B. Enbert, NF1 Inactivation Revs Up Ras in Adult Acute Myelogenous Leukemia, Clinical Cancer Research, vol.16, issue.16, pp.16-4074, 2010.
DOI : 10.1158/1078-0432.CCR-10-1438

R. Murr, J. Loizou, and Y. Yang, Histone acetylation by Trrap???Tip60 modulates loading of repair proteins and repair of DNA double-strand breaks, Nature Cell Biology, vol.12, issue.1, pp.91-99, 2006.
DOI : 10.1093/nar/gkg902

T. Naoe, K. Takeyama, and T. Yokozawa, Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/ myelodysplastic syndrome and de novo acute myeloid leukemia, Clin Cancer Res, issue.10, pp.6-4091, 2000.

T. Nguyen, L. Ma, and M. Slovak, Identification of novel Runx1 (AML1) translocation partner genes SH3D19, YTHDf2, and ZNF687 in acute myeloid leukemia, Genes Chromosomes Cancer, issue.10, pp.45-918, 2006.

B. Niebuhr, M. Fischer, and M. Täger, Gatekeeper function of the RUNX1 transcription factor in acute leukemia, Blood Cells, Molecules, and Diseases, vol.40, issue.2, pp.40-211, 2008.
DOI : 10.1016/j.bcmd.2007.07.018

M. Nishiyama, Y. Arai, and Y. Tsunematsu, 11p15 translocations involving the NUP98 gene in childhood therapy???related acute myeloid leukemia/myelodysplastic syndrome, Genes, Chromosomes and Cancer, vol.26, issue.3, pp.215-220, 1999.
DOI : 10.1002/(SICI)1098-2264(199911)26:3<215::AID-GCC5>3.3.CO;2-T

P. Nowell, The clonal evolution of tumor cell populations, Science, vol.194, issue.4260, pp.194-217, 1976.
DOI : 10.1126/science.959840

M. Osato, Point mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia, Oncogene, vol.23, issue.24
DOI : 10.1038/sj.onc.1207779

I. Panagopoulos, C. Storlazzi, and C. Fletcher, The chimeric FUS/CREB3l2 gene is specific for low-grade fibromyxoid sarcoma, Genes Chromosomes Cancer, issue.3, pp.40-218, 2004.

T. Papas, D. Watson, and N. Sacchi, ETS family of genes in leukemia and Down syndrome, American Journal of Medical Genetics, vol.226, issue.S7, pp.251-261, 1990.
DOI : 10.1002/ajmg.1320370751

Y. Shiloh, ATM and related protein kinases: safeguarding genome integrity, Nature Reviews Cancer, vol.12, issue.3, pp.155-168, 2003.
DOI : 10.1038/nrc1011

H. Schmetzer, S. Braun, and D. Wiesner, Gene Rearrangements in Bone Marrow Cells of Patients with Acute Myelogenous Leukemia, Acta Haematologica, vol.103, issue.3, pp.125-134, 2000.
DOI : 10.1159/000041035

S. Schnittger, U. Kinkelin, and C. Schoch, Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML, Leukemia, vol.14, issue.5, pp.14-796, 2000.
DOI : 10.1038/sj.leu.2401773

S. Schnittger, C. Schoch, and W. Kern, Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype, Blood, vol.106, issue.12, pp.106-3733, 2005.
DOI : 10.1182/blood-2005-06-2248

S. Schnittger, F. Dicker, and W. Kern, RUNX1 mutations are frequent in de novo AML with noncomplex karyotype and confer an unfavorable prognosis, Blood, vol.117, issue.8, pp.117-2348, 2011.
DOI : 10.1182/blood-2009-11-255976

C. Schoch, T. Haferlach, and S. Bursch, Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: A detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH, Genes, Chromosomes and Cancer, vol.311, issue.Suppl 1, pp.35-55, 2002.
DOI : 10.1002/gcc.10088

C. Schoch, W. Kern, S. Schnittger, W. Hiddemann, and T. Haferlach, Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukaemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML, Leukemia, issue.1, pp.18-120, 2004.

S. Schwind, K. Maharry, and M. Radmacher, , in Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study, Journal of Clinical Oncology, vol.28, issue.36, pp.5257-5264, 2010.
DOI : 10.1200/JCO.2010.29.2953

C. Seedhouse, R. Bainton, and M. Lewis, The genotype distribution of the XRCC1 gene indicates a role for base excision repair in the development of therapy-related acute myeloblastic leukemia, Blood, vol.100, issue.10, pp.100-3761, 2002.
DOI : 10.1182/blood-2002-04-1152

C. Seedhouse, R. Faulkner, and N. Ashraf, Polymorphisms in Genes Involved in Homologous Recombination Repair Interact to Increase the Risk of Developing Acute Myeloid Leukemia, Clinical Cancer Research, vol.10, issue.8, pp.10-2675, 2004.
DOI : 10.1158/1078-0432.CCR-03-0372

C. Seedhouse and N. Russell, Advances in the understanding of susceptibility to treatment-related acute myeloid leukaemia, British Journal of Haematology, vol.94, issue.1, pp.513-529, 2007.
DOI : 10.1111/j.1432-1033.1994.00893.x

V. Sementchenko, C. Schweinfest, and T. Papas, ETS2 function is required to maintain the transformed state of human prostate cancer cells, Oncogene, vol.17, issue.22, pp.17-2883, 1998.
DOI : 10.1038/sj.onc.1202220

C. Sevignani, P. Wlodarski, and J. Kirilova, Tumorigenic conversion of p53-deficient colon epithelial cells by an activated Ki-ras gene., Journal of Clinical Investigation, vol.101, issue.8, pp.101-1572, 1998.
DOI : 10.1172/JCI919

K. Shannon, O. Connell, P. Martin, and G. , Loss of The Normal NF1 Allele from the Bone Marrow of Children with Type 1 Neurofibromatosis and Malignant Myeloid Disorders, New England Journal of Medicine, vol.330, issue.9, pp.330-597, 1994.
DOI : 10.1056/NEJM199403033300903

D. Silberberg, L. Frohman, and I. Duffy, The incidence of leukemia and related diseases in patients with rheumatoid (ankylosing) spondylitis treated with X-ray therapy, Arthritis & Rheumatism, vol.2, issue.1, pp.64-75, 1960.
DOI : 10.1002/art.1780030108

F. Silva, I. Almeida, and B. Morolli, Genome wide molecular analysis of minimally differentiated acute myeloid leukemia, Haematologica, vol.94, issue.11, pp.94-1546, 2009.
DOI : 10.3324/haematol.2009.009324

C. Skjelbred, M. Saebo, and A. Hjartaker, Meat, vegetables and genetic polymorphisms and the risk of colorectal carcinomas and adenomas, BMC Cancer, vol.14, issue.4, 2007.
DOI : 10.1097/00008469-200508000-00010

A. Smith, L. Worrillow, and J. Allan, A common genetic variant in XPD associates with risk of 5q- and 7q-deleted acute myeloid leukemia, Blood, vol.109, issue.3, pp.1233-1236, 2007.
DOI : 10.1182/blood-2006-07-037853

S. Smith, L. Beau, M. Huo, and D. , Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series, Blood, vol.102, issue.1, pp.43-52, 2003.
DOI : 10.1182/blood-2002-11-3343

R. Sobol, J. Horton, and R. Kühn, Requirement of mammalian DNA polymerase beta in base excision repair, Nature, issue.6561, pp.379-183, 1996.

R. Sobol, R. Prasad, and A. Evenski, The lyase activity of the DNA repair protein ?polymerase protect from DNA damage-induced cytotoxicity, Nature, issue.6788, pp.405-807, 2000.

H. Song, H. Kim, and J. Piao, Association of a common genetic variant in prostate stemcell antigen with gastric cancer susceptibility in a Korean population, Mol Carcinol, 2011.

W. Song, M. Sullivan, and R. Legare, Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia, Nat Genet, vol.23, issue.2, pp.166-175, 1999.

E. Sonoda, M. Sasaki, and J. Buerstedde, Rad51-deficient vertebrate cells accumulate chromosomal breaks prior to cell death, The EMBO Journal, vol.17, issue.2, pp.598-608, 1998.
DOI : 10.1093/emboj/17.2.598

L. Sreeja, V. Syamala, and S. Hariharan, Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients, J Exp Ther Oncol, vol.7, issue.1, pp.73-85, 2008.

M. Stankiewicz and J. Crispino, ETS2 and ERG promote megakaryopoiesis and synergize with alterations in GATA-1 to immortalize hematopoietic progenitor cells, Blood, vol.113, issue.14, pp.113-3337, 2009.
DOI : 10.1182/blood-2008-08-174813

M. Stanulla, J. Wang, D. Chervinsky, and P. Aplan, Topoisomerase II inhibitors induce DNA double-strand breaks at a specific site within the AML1 locus, Leukemia, vol.11, issue.4, pp.490-496, 1997.
DOI : 10.1038/sj.leu.2400632

L. Staudt, Oncogenic activation of NF-kappaB, Cold Spring Harb Perspect Biol, issue.26, p.109, 2010.

N. Wald, Leukemia in Hiroshima City Atomic Bomb Survivors, Science, vol.127, issue.3300, pp.127-699, 1958.
DOI : 10.1126/science.127.3300.699

M. Walter, J. Payton, and R. Ries, Acquired copy number alterations in adult acute myeloid leukemia genomes, Proceedings of the National Academy of Sciences, vol.106, issue.31, pp.106-12950, 2009.
DOI : 10.1073/pnas.0903091106

M. Walter, D. Shen, and . Ding, Clonal Architecture of Secondary Acute Myeloid Leukemia, New England Journal of Medicine, vol.366, issue.12
DOI : 10.1056/NEJMoa1106968

J. Wang, G. Xiang, and K. Mitchelson, Microarray profiling of monocytic differentiation reveals miRNA-mRNA intrinsic correlation, Journal of Cellular Biochemistry, vol.215, issue.9, pp.2443-2453, 2011.
DOI : 10.1002/jcb.23165

L. Wang, W. Swat, and Y. Fujiwara, The TEL/ETV6 gene is required specifically for hematopoiesis in the bone??marrow, Genes & Development, vol.12, issue.15, pp.12-2392, 1998.
DOI : 10.1101/gad.12.15.2392

P. Ward, J. Patel, and D. Wise, The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2- hydroxyglutarate, Cancer Cell, issue.3, pp.17-225, 2010.

E. Wattel, C. Preudhomme, and B. Hecquet, p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies, Blood, vol.84, issue.9, pp.3148-3157, 1994.

J. Welch, P. Westervelt, and L. Ding, Use of Whole-Genome Sequencingto diagnose a cryptic fusion oncogen, JAMA, issue.15, pp.305-1577, 2011.

J. Welch and D. Link, Genomics of AML: Clinical Applications of Next-Generation Sequencing, Hematology, vol.2011, issue.1, pp.30-35, 2011.
DOI : 10.1182/asheducation-2011.1.30

C. Whitehouse, R. Taylor, and A. Thistlethwaite, XRCC1 Stimulates Human Polynucleotide Kinase Activity at Damaged DNA Termini and Accelerates DNA Single-Strand Break Repair, Cell, vol.104, issue.1, pp.107-117, 2001.
DOI : 10.1016/S0092-8674(01)00195-7
URL : http://doi.org/10.1016/s0092-8674(01)00195-7

K. Wong, R. De-leeuw, and N. Dosanjh, A Comprehensive Analysis of Common Copy-Number Variations in the Human Genome, The American Journal of Human Genetics, vol.80, issue.1, pp.91-104, 2007.
DOI : 10.1086/510560

K. Woo, K. Kim, and K. Kh, Deletions of chromosome arms 7p and 7q in adult acute myeloid leukemia: a marker chromosome confirmed by array comparative genomic hybridization, Cancer Genetics and Cytogenetics, vol.194, issue.2, pp.194-71, 2009.
DOI : 10.1016/j.cancergencyto.2009.04.017

L. Worrillow, L. Travis, and A. Smith, An intron splice acceptor polymorphism in hMSH2 and risk of leukemia after treatment with chemotherapeutic alkylating agents, Clin Cancer Res, issue.98, pp.3012-3020, 2003.

L. Worrillow and A. , Deregulation of homologous recombination DNA repair in alkylating agent-treated stem cell clones: a possible role in the aetiology of chemotherapy-induced leukaemia, Oncogene, vol.94, issue.12, pp.25-1709, 2006.
DOI : 10.1038/sj.onc.1209208

M. Xu-welliver and A. Pegg, Degradation of the alkylated form of the DNA repair protein, O6-alkylguanine-DNA alkyltransferase, Carcinogenesis, vol.23, issue.5, pp.823-830, 2002.
DOI : 10.1093/carcin/23.5.823

N. Itzhar, P. Dessen, S. Toujani, N. Auger, C. Preudhomme et al., Chromosomal minimal critical regions in therapy-related leukemia appear different from those of de novo leukemia by highresolution aCGH. PLoS One, Feb, vol.146, issue.2, p.16623, 2011.

S. Toujani, P. Dessen, and N. Itzhar, High Resolution Genome-Wide Analysis of Chromosomal Alterations in Burkitt's Lymphoma, PLoS ONE, vol.446, issue.9, p.7089, 2009.
DOI : 10.1371/journal.pone.0007089.s013

A. Berceanu, S. Toujani, D. Costa, L. Itzhar, N. Lapusan et al., An unusual case of a lymphoblastic lymphoma with initial bilateral breast lesions but with c-myc and bcl- 2 rearrangements. Leuk Lymphoma, pp.48415-417, 2007.